Kuo-Chen Hung
Papers
1
Total Citations
12
H-Index
1
About
Dr. Kuo-Chen Hung is a surgical oncologist whose work focuses on pushing the boundaries of treatment for advanced abdominal cancers, particularly peritoneal metastases. His most cited research, a 2020 study on cytoreduction surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for hepatocellular carcinoma (HCC-PM), addresses a critical gap in oncology. While CRS/HIPEC has proven effective for other malignancies, its role in HCC-PM was unclear. Dr. Hung’s work provides foundational evidence for this aggressive approach, offering a potential lifeline for patients with limited options. With 12 citations, this paper is a cornerstone for clinicians exploring multimodal therapies for HCC. Beyond this, his broader research portfolio investigates innovative surgical strategies for liver and peritoneal tumors, aiming to improve survival and quality of life. Dr. Hung’s contributions are particularly notable for tackling a notoriously difficult-to-treat condition, demonstrating both surgical precision and a commitment to advancing care for underserved patient populations. His work continues to inspire further clinical trials and multidisciplinary collaboration in hepatobiliary oncology.
Research Focus
Key Achievements
Top Papers
- 1